Research ArticleCancer

Trispecific CD19-CD20-CD22–targeting duoCAR-T cells eliminate antigen-heterogeneous B cell tumors in preclinical models

See allHide authors and affiliations

Science Translational Medicine  24 Mar 2021:
Vol. 13, Issue 586, eabc6401
DOI: 10.1126/scitranslmed.abc6401

Log in to view full text

Log in through your institution

Log in through your institution

Stay Connected to Science Translational Medicine

Navigate This Article